Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | AKT1 | P31749 | 2/20 | 0.56 |
| ▸ | ESR1 | P03372 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | CDC25A | P30304 | 1/20 | 0.56 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.56 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.45 |
| ▸ | PTAFR | P25105 | 1/20 | 0.45 |
| ▸ | HTR1D | P28221 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.45 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.43 |
| ▸ | PRKCG | P05129 | 1/20 | 0.43 |
| ▸ | PRKCB | P05771 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21631754 | 0.80 | LMNA (0.67) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL3135948 | 0.80 | FABP3 (0.42) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL8911477 | 0.80 | LMNA (0.53) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL1853865 | 0.79 | SMN1; SMN2 (0.70) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL5476581 | 0.79 | SMN1; SMN2 (0.49) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL19734900 | 0.77 | SMN1; SMN2 (0.60) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL20090040 | 0.77 | LMNA (0.62) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL4972574 | 0.77 | LMNA (0.86) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL26756555 | 0.77 | LMNA (0.73) | LMNAAKT1ESR1ADORA3CDC25A | |
| SCHEMBL8911167 | 0.77 | LMNA (0.58) | LMNAAKT1ESR1ADORA3CDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8318865-B2 | Eye lens material and method of manufacturing thereof | SHISEIDO COMPANY, LTD. (JP) | 2012-11-27 | — | — | US | claimed |
| US-8277834-B2 | Method for producing protein adsorption-preventing ocular lens material | SHISEIDO COMPANY, LTD. (JP) | 2012-10-02 | — | — | US | claimed |
| WO-2025029860-A1 | DRUG CONJUGATES AND METHODS OF PREPARING AND USING THE SAME | ADCENTRX THERAPEUTICS INC. (US) | 2025-02-06 | — | — | WO | disclosed |
| US-20230257485-A1 | GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT | 2023-08-17 | — | — | US | disclosed |
| US-11673974-B2 | Glycophospholipid polymeric network and use thereof | BAUSCH & LOMB INCORPORATED (US) | 2023-06-13 | — | — | US | disclosed |
| US-8318865-B2 | Eye lens material and method of manufacturing thereof | SHISEIDO COMPANY, LTD. (JP) | 2012-11-27 | — | — | US | disclosed |
| US-8277834-B2 | Method for producing protein adsorption-preventing ocular lens material | SHISEIDO COMPANY, LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| EP-1750127-B1 | Method of affinity separation. | SHISEIDO CO LTD (JP) | 2011-07-20 | — | — | EP | disclosed |
| US-20090321358-A1 | Affinity Particle And Method Of Affinity Separation | SHISEIDO COMPANY, LTD. (JP) | 2009-12-31 | — | — | US | disclosed |
| US-20080300369-A1 | Eye Lens Material and Method of Manufacturing Thereof | SHISEIDO COMPANY, LTD. (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080300375-A1 | Ocular Lens Material and Method for Producing Same | ISHIHARA, KAZUHIKO (10% OWNERSHIP) (JP) | 2008-12-04 | — | — | US | disclosed |
| US-20080038221-A1 | Method For Producing Protein Adsorption-Preventing Ocular Lens Material | SHISEIDO COMPANY, LTD. (JP) | 2008-02-14 | — | — | US | disclosed |
| US-20070241054-A1 | Affinity Particle And Method Of Affinity Separation | SHISEIDO COMPANY, LTD. (JP) | 2007-10-18 | — | — | US | disclosed |
| EP-1750127-A1 | AFFINITY PARTICLE AND METHOD OF AFFINITY SEPARATION | Shiseido Company, Limited (JP) | 2007-02-07 | — | — | EP | disclosed |
| EP-1750158-A1 | OCULAR LENS MATERIAL AND METHOD FOR PRODUCING SAME | Shiseido Company, Limited (JP) | 2007-02-07 | — | — | EP | disclosed |
| EP-1750159-A1 | OCULAR LENS MATERIAL AND METHOD FOR PRODUCING SAME | Shiseido Company, Limited (JP) | 2007-02-07 | — | — | EP | disclosed |
| EP-1750160-A1 | METHOD FOR PRODUCING PROTEIN ADSORPTION-PREVENTING OCULAR LENS MATERIAL | Shiseido Company, Limited (JP) | 2007-02-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11673974-B2 | Glycophospholipid polymeric network and use thereof | ALG1, CSGALNACT1, FUT5 | LMNA 2758/4885AKT1 4039/4885ESR1 3941/4885 |
| US-20230257485-A1 | GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF | ALG1, CSGALNACT1, FUT6 | LMNA 2560/4885AKT1 3377/4885ESR1 2552/4885 |
| US-20080038221-A1 | Method For Producing Protein Adsorption-Preventing Ocular Lens Material | PCTP, CRYAA, PHOSPHO1 | LMNA 557/4885AKT1 718/4885ESR1 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.